P0764: Are anticoagulants safe in patients with Inflammatory Bowel Disease?ECCO'25Year: 2025
Authors: Rivas, C.(1)*;García, M.J.(1);Alonso Fernández, S.(1);Castro, B.(1);Cuadrado, A.(1);Rivero, M.(1);
(1)Gastroenterology and Hepatology Department- Clinical and Translational Research in Digestive Diseases- Valdecilla Research Institute IDIVAL- Marqués de Valdecilla University Hospital- Santander- Spain, Gastroenterology and Hepatology Department, Santander, Spain;
- S. Schulman, C. Kearon. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost., 3 (2005), pp. 692-694 http://dx.doi.org/10.1111/j.1538-7836.2005.01204.x | Medline
- Cea-Calvo L, Redón J, Lozano JV, et al. Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS. Rev Esp Cardiol. 2007; 60: 616-24
- Gu ZC, Wei AH, Zhang C, Wang XH, Zhang L, Shen L, Li Z, Pan MM, Liu XY, Pu J, Lin HW. Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2020 Apr;18(4):792-799.e61. doi: 10.1016/j.cgh.2019.05.056. Epub 2019 Jun 11. PMID: 31195162.
- Viola A, Chiappetta MF, Scolaro M, Bignoli F, Versace A, Fries W. Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease. Dig Liver Dis. 2020 Dec;52(12):1525-1526. doi: 10.1016/j.dld.2020.08.033. Epub 2020 Sep 6. PMID: 32900651.
P0766: Rate and predictors of successful anti-TNF de-escalation in dose escalated IBD patients. A real-world Greek - Turkish collaborative study.ECCO'25Year: 2025
Authors: Viazis, N.(1)*;Toruner , M.(2);Papastergiou, V.(1);Mousourakis, K.(1);Christidou, A.(1);Tzouvala, M.(3);Zacharopoulou, E.(3);Theocharis, G.(4);Geramoutsos, G.(4);Theodoropoulou, A.(5);Velegraki, M.(5);Çelik, A.F.(6);Akpinar, A.(6);Zampeli, E.(7);Papathanasiou, E.(7);Unal, N.G.(8);Kapsoritakis, A.(9);Argyriou, K.(10);Christodoulou, D.(11);Fousekis, F.(11);Karakan, T.(12);Koutroubakis, I.(13);Drygiannakis, I.(13);Giouleme, O.(14);Kalogirou, M.(14);Liatsos, C.(15);Kyriakos, N.(15);Tsironi, E.(16);Markopoulos, P.(16);Bamias, G.(17);Chalakatevaki, K.(17);Tsiolakidou, G.(18);Tribonias, G.(19);Kasapidis, P.(20);Paraskeva, K.(21);Telli, P.(22);Akyuz, F.(22);
(1)Evangelismos General Hospital, Gastroenterology, Athens, Greece;(2)Ankara University, Gastroenterology, Ankara, Turkey;(3)General Hospital Nikaia Piraeus- “Agios Panteleimon”, Gastroenterology, Athens, Greece;(4)University Hospital of Patras, Gastroenterology, Patras, Greece;(5)Venizeleio General Hospital, Gastroenterology, Heraklion, Greece;(6)University of Istanbul- Cerrahpasa, Gastroenterology, Istanbul, Turkey;(7)General Hospital Alexandra, Gastroenterology, Athens, Greece;(8)Ege University, Gastroenterology, Izmir, Turkey;(9)University Hospital of Larisa, University Hospital of Larisa, Larisa, Greece;(10)University Hospital of Larisa, Gastroenterology, Larisa, Greece;(11)University Hospital of Ioannina, Gastroenterology, Ioannina, Greece;(12)Gazi University, Gastroenterology, Ankara, Turkey;(13)University Hospital of Heraklion, Gastroenterology, Heraklion, Greece;(14)Second Propedeutic Department of Internal Medicine- Hippokration General Hospital, Gastroenterology, Thessaloniki, Greece;(15)401 Military Hospital, Gastroenterology, Athens, Greece;(16)Metaxa Hospital, Gastroenterology, Athens, Greece;(17)Sotiria Hospital, Gastroenterology, Athens, Greece;(18)General Hospital of Kavala, Gastroenterology, Kavala, Greece;(19)Erythros Stavros Hospital, Gastroenterology, Athens, Greece;(20)White Cross Hospital, Gastroenterology, Athens, Greece;(21)Konstantopouleio General Hospital, Gastroenterology, Athens, Greece;(22)Istanbul Faculty of Medicine- Istanbul University, Gastroenterology, Istanbul, Turkey; Kostas Karmiris Kostas Katsanos Maria Palatianou Evangelina Vlachou Charikleia Lamouri Konstantina Dimopoulou
P0767: Sub-optimal adherence with vaccination recommendations in immunosuppressed IBD patients in the post COVID-19 pandemic eraECCO'25Year: 2025
Authors: Decker, V.(1)*;Shakweh, E.(1,2);Rejee, C.(2);Hart, A.(1,2);Alexander, J.L.(1,2,3);
(1)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(2)St Mark’s Hospital The National Bowel Hospital and Academic Institute, Gastroenterology, London, United Kingdom;(3)Imperial College NHS Healthcare Trust, Gastroenterology and Hepatology, London, United Kingdom;
1. Malhi G, Rumman A, Thanabalan R, et al. Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge, and Uptake. Journal of Crohn's and colitis. 2015;9(6):439–444. doi:10.1093/ecco-jcc/jjv0642.
2. Cunniff L, Alyanak E, Fix A, et al. The impact of the COVID-19 pandemic on vaccination uptake in the United States and strategies to recover and improve vaccination rates: A review. Human vaccines & immunotherapeutics. 2023;19(2):2246502. doi:10.1080/21645515.2023.22465023.
3. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi:10.1136/gutjnl-2019-3184844.
4. UK Health Security Agency. Immunisation of individuals with underlying medical conditions. In: Ramsay DM, ed. The Green Book: Immunisation against infectious disease UK Health Security Agency; 2013:1–8
P0768: Ultra Processed Food in Inflammatory Bowel Disease – Friend or Foe? An examination into the contribution of UPFs to nutrient intake in an IBD remission cohort.ECCO'25Year: 2025
Authors: Katarachia , V.(1);Westoby, C.(1)*;McDonnell, M.(2);Sartain, S.(2);Cummings, J.R.F.(2);Wooton, S.(3);
(1)University Hospital Southampton NHS Foundation Trust, Nutrition and Dietetics, Southampton, United Kingdom;(2)University Hospital Southampton NHS Foundation Trust, Gastroenterology, Southampton, United Kingdom;(3)University of Southampton, Faculty of Medicine, Southampton, United Kingdom; INTICO 2
1) Holt D.Q., Strauss B.J. & Moore G.T. (2017) Patients with inflammatory bowel disease and their treating clinicians have different views regarding diet. J Hum Nutr Diet. 30, 66–72 doi: 10.1111/jhn.12400
2) SACN statement on processed foods and health. GOV.UK. https://www.gov.uk/government/publications/sacn-statement-on-processed-foods-and-healthOffice. SACN statement on processed foods and health - summary report. GOV.UK. Published July 11, 2023. https://www.gov.uk/government/publications/sacn-statement-on-processed-foods-and-health/sacn-statement-on-processed-foods-and-health-summary-report#results
P0769: Impact of Nurse-Led Day Case Management of Acute Inflammatory Bowel Disease Flares on Admissions to HospitalECCO'25Year: 2025
Authors: Lloyd-Ford, G.(1)*;Bowler, N.(2);Lewis, A.(3);Gordon, M.(3);Haviland, S.(3);Hill, J.(3);
(1)Aneurin Bevan University Health Board, Department of Gastroenterology & Hepatology, Newport, United Kingdom;(2)Aneurin Bevan University Health Borad, Gastroenterology, Newport, United Kingdom;(3)Aneurin Bevan University Health Board, Gastroenterology, Newport, United Kingdom;
Sturm A and White L (2019) Inflammatory Bowel Disease Nursing Manual. Springer
P0770: Assessing the level of anxiety among patients attending an IBD surveillanceECCO'25Year: 2025
Authors: White, L.(1);Sundramoorthi, R.(2)*;Mohan, S.(2);Johnston , E.(2);
(1)West Middlesex University Hospital, Gatroenterology, London, United Kingdom;(2)West Middlesex University Hospital, Gastroenterology, London, United Kingdom;
(1) Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press
(2) Shaikh AA, Hussain SM, Rahn S, Desilets DJ. Effect of an educational pamphlet on colon cancer screening: a randomized, prospective trial. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):444-9. doi: 10.1097/MEG.0b013e328333fca6. PMID: 19940781.
P0771: Early Infliximab Rescue therapy is associated with reduced length of stay in patients with acute severe ulcerative colitisECCO'25Year: 2025
Authors: Mohamedrashed, M.(1);Yogakanthi, S.(1);Xu, C.(1);Bartlett, R.(1);Chew, M.(1);Nedumannil , L.(1);Lucas, S.(1);Chauhan, A.(1);Lewis, D.(1);Kashkooli, S.(1);Garg, M.(1)*;
(1)Northern Health, Gastroenterology, Melbourne, Australia;
P0772: Efficacy and consumption of golimumab is similar with European and American dosing regimens in Ulcerative Colitis: Results of a prospective studyECCO'25Year: 2025
Authors: Milanez, I.(1)*;Finderle, S.(1);Hanžel, J.(1,2);Novak, G.(1,2);Koželj, M.(1);Smrekar, N.(1,2);Marušič, T.(3);Bukovnik, N.(4);Ocepek, A.(4);Polanc, T.(1);Planinšek, A.(1);Bobnar Sekulić, C.(1);Drobne, D.(1,2);
(1)University Medical Centre Ljubljana, Department of Gastroenterology, Ljubljana, Slovenia;(2)University of Ljubljana, Medical Faculty, Ljubljana, Slovenia;(3)General Hospital Izola, Department of Gastroenterology, Izola, Slovenia;(4)University Medical Centre Maribor, Department of Gastroenterology, Maribor, Slovenia;
1. Hanzel J, Drobne D. Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring. Aliment Pharmacol Ther. 2023 Jun;57(12):1469–70.
2. Stefanovic S, Detrez I, Compernolle G, Brouwers E, Sever N, Stabuc B, et al. Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. Eur J Gastroenterol Hepatol. 2021 Jan;33(1):54–61.
3. Fumery M, Nancey S, Filippi J, Altwegg R, Hébuterne X, Boshetti G, et al. Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Aliment Pharmacol Ther. 2023 Jun;57(11):1290–8.
4. Dreesen E, Kantasiripitak W, Detrez I, Stefanović S, Vermeire S, Ferrante M, et al. A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2020 Mar 4;26(4):570–80.
P0773: Real-World Application of Intestinal Ultrasound for Monitoring Ulcerative Colitis in South Korea.ECCO'25Year: 2025
Authors: Kim , K.W.(1)*;Jeong , J.(1);Noh , H.D.(1);Lee , H.J.(2);Koh , S.J.(2);Kang , H.W.(1);Im , J.P.(2);Kim , B.G.(2);Kim , J.S.(2);Lee , K.L.(1);Kim , J.W.(1);
(1)Seoul National University Boramae Medical Center- Seoul National University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(2)Seoul National University Hospital- Seoul National University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;
1. Allocca M, Dell'Avalle C, Furfaro F, et al. Early Intestinal Ultrasound Predicts Long-Term Endoscopic Response to Biologics in Ulcerative Colitis. J Crohns Colitis. 2023;17(10):1579-1586.
P0774: Key elements of high quality and sustainable IBD care: the common eye from an inter-, and intra stakeholder perspectiveECCO'25Year: 2025
Authors: Thomassen, B.(1,2,3)*;Hendrix, E.(1,3);Mujagic, Z.(1,3);Smeets, F.(4);De Jong, M.(5);Gevers, T.(1,3);Veldhuijzen, G.(6,7);Van der Horst, D.(8);Scherpenzeel, M.(8);Dijkstra, G.(9);Kimman, M.(10,11);Ament, S.(12);Pierik, M.(1,3);
(1)Maastricht University Medical Center+, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands;(2)Maastricht University Medical Center+, Department of Surgery, Maastricht, The Netherlands;(3)Maastricht University, Institute for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht, The Netherlands;(4)St. Jans Gasthuis, Department of Gastroenterology and Hepatology, Weert, The Netherlands;(5)Horacio Oduber Hospital, Deparment of Gastroenterology and Hepatology, Oranjestad, Aruba;(6)Gelre Hospitals, Department of Gastroenterology and Hepatology, Apeldoorn, The Netherlands;(7)Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(8)Crohn & Colitis Netherlands, Crohn & Colitis Netherlands, Woerden, The Netherlands;(9)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(10)Maastricht University Medical Center+, Department of Clinical Epidemiology and Medical Technology Assessment KEMTA, Maastricht, The Netherlands;(11)Maastricht University, Care and Public Health Research Institute CAPHRI, Maastricht, The Netherlands;(12)Maastricht University Medical Center+, Department of Innovation - Centre of Expertise Quality- Innovation & Research, Maastricht, The Netherlands;
P0775: The IBD Specialist Pharmacist actively contributes to the IBD clinical team, providing significant benefits and enhancements to patient careECCO'25Year: 2025
Authors: Garcia Fuertes, F.(1)*;Lee, H.(1);Sundar, N.(2);Shirazi-Nejad, A.(2);Bullas, D.(2);Hyde, L.(2);Gray, R.(2);Atkinson, R.(2);
(1)Barnsley Hospital NHS Foundation Trust, Pharmacy, Barnsley, United Kingdom;(2)Barnsley Hospital NHS Foundation Trust, Gastroenterology, Barnsley, United Kingdom;
1. King D, et al., Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000–2018. Aliment Pharmacol Ther. 2020;51(10):922–34
2. IBD UK. IBD standards 2019. www.IBDUK.org (accessed August 2024).
P0776: EVOKE - Evaluation of the long-term outcomes of Crohn’s disease complicating intra-abdominal abscess - retrospective, multicentre cohort studyECCO'25Year: 2025
Authors: Bacsur , P.(1);Nemeczek , S.(2,3);Filip , R.(2,3);Fotios , F.(4);Mpakogiannis , K.(4);Pastras , P.(5);Blesl , A.(6);Vieujean , S.(7);Gatt , Y.(8);Brinar , M.(9);Kagramanova , A.(10);Iliás , Á.(11);Gönczi , L.(11);Miheller , P.(12);Resál , T.(1,13);Ivány , E.(1);Farkas , B.(1);Bálint , A.(1);Fábián , A.(1);Bor , R.(1);Rutka , M.(1);Bősze , Z.(1);Szepes , Z.(1);Farkas , K.(1,14);Molnár , T.(1)*;
(1)Albert Szent-Györgyi Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)Clinical Hospital No. 2, Department of Gastroenterology with IBD Unit, Rzeszow, Poland;(3)Medical College of Rzeszow University, Institute of Medicine, Rzeszow, Poland;(4)Faculty of Medicine- School of Health Sciences- University of Ioannina, Division of Gastroenterology- Department of Internal Medicine, Ioannina, Greece;(5)University Hospital of Patras, Division of Gastroenterology- Department of Internal Medicine, Patras, Greece;(6)Medical University of Graz, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Graz, Austria;(7)University Hospital CHU of Liège, Department of Gastroenterology, Liège, Belgium;(8)Mater Dei Hospital, Department of Gastroenterology, Msida, Malta;(9)University Hospital Centre Rebro- Medical School- University of Zagreb, Day Hospital- Department of Gastroenterology and Hepatology, Zagreb, Croatia;(10)Moscow Clinical Scientific Center named after A.S. Loginov, Moscow Clinical Scientific Center named after A.S. Loginov, Moscow, Russian Federation;(11)Semmelweis University, Department of Internal Medicine and Oncology, Budapest, Hungary;(12)Semmelweis University, Department of Surgery- Transplantation and Gastroenterology, Budapest, Hungary;(13)Central Hospital of Northern Pest - Military Hospital, Department of Gastroenterology, Budapest, Hungary;(14)HCEMM-USZ, Translational Colorectal Research Group, Szeged, Hungary; Collaborators: Katsanos Konstantinos, Christos Triantos, Pierre Ellul, Zeljko Krznaric, Magdalena Gawron-Kiszka
P0777: Sonographic transmural induction outcomes across advanced therapies in Crohn’s DiseaseECCO'25Year: 2025
Authors: Smyth, M.(1)*;Dolinger, M.(2);Dubinsky, M.(3);
(1)University of British Columbia, Pediatric Gastroenterology, Vancouver, Canada;(2)Icahn school of Medicine at Mount Sinai, Pediatric Gastroenterology, New York, United States;(3)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;
P0778: Exploring the impact of personalised and curated educational videos delivered via an online platform to paediatric IBD patients.ECCO'25Year: 2025
Authors: Tucknott, S.(1,2)*;Rose, J.(2);Sivananthan, A.(2);Glemas, C.(2);Heuschkel, R.(2);Zilbauer, M.(2,3);
(1)IBD Relief Ltd, IBDrelief, London, United Kingdom;(2)Cambridge University Hospitals NHS Foundation Trust, Department of Paediatric Gastroenterology- Hepatology and Nutrition, Cambridge, United Kingdom;(3)University of Cambridge, Department of Paediatrics, Cambridge, United Kingdom;
P0779: Resting-state MRI data fusion reveals distinct disease-state dependent patterns for fatigue, depression and anxiety in Crohn’s DiseaseECCO'25Year: 2025
Authors: Thomann, A.(1)*;Schmitgen, M.(2);Stephan, J.C.(1);Knoedler, L.L.(1);Thomann, P.A.(3);Ebert, M.P.(1);Szabo, K.(4);Reindl, W.(1);Wolf, R.C.(2);
(1)Medical Faculty Mannheim- Heidelberg University, Department of Medicine II, Mannheim, Germany;(2)Center for Psychosocial Medicine- Heidelberg University Hospital, Department of General Psychiatry, Heidelberg, Germany;(3)SRH Clinic Karlsbad-Langensteinbach, Department of Psychiatry and Psychotherapy, Karlsbad, Germany;(4)Medical Faculty Mannheim- Heidelberg University, Department of Neurology, Mannheim, Germany;
P0780: Impact of Hyperbaric Oxygen Therapy on Perianal Fistulas in Crohn’s Disease: Clinical Outcomes and Remission RatesECCO'25Year: 2025
Authors: Piotrowicz, G.(1)*;Rudnik, A.(1,2,3);Kot, J.(4,5); Babicki, A.(6);Banaszkiewicz, P.(1);Piotrowicz, A.(6);Rzeszutek, M.(1);Zientara, P.(7);Adamska-Mieruszewska, J.(7);Rydzewska, G.(8);
(1)Self-Dependent Health Care Unit of Ministry of Interior and Administration, Department of Gastroenterology, Gdansk, Poland;(2)University of Gdansk, Institute of Psychology, Gdańsk, Poland;(3)University of Gdansk, Academic Psychological Support Centre, Gdansk, Poland;(4)Medical University of Gdansk, National Centre for Hyperbaric Medicine Institute of Maritime and Tropical Medicine in Gdynia, Gdansk, Poland;(5)University Centre for Maritime and Tropical Medicine, Department of Hyperbaric Medicine and Sea Rescue, Gdynia, Poland;(6)Self-Dependent Health Care Unit of Ministry of Interior and Administration, Department of Surgery, Gdansk, Poland;(7)University of Gdansk, Faculty of Economics, Gdansk, Poland;(8)Central Clinical Hospital of the Ministry of Interior and Administration, Department of Internal Medicine and Gastroenterology, Warsaw, Poland;
1. Feroz SH, Ahmed A, Muralidharan A, Thirunavukarasu P. Comparison of the efficacy of the various treatment modalities in the management of perianal Crohn’s fistula: a review. Cureus. 2020;12(12).
2. Cheifetz AS. Management of active Crohn disease. Jama. 2013;22;309(20):2150-8.
3. Cushing K, Higgins PD. Management of Crohn disease: a review. Jama. 2021;325(1):69-80.
4. Parra RS, Féres O, Lansdorp CA. Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?. United European Gastroenterology Journal. 2022;10(3):346.
5. Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, Kopylov U, Yanai H, Vavricka SR, Sigall-Boneh R, Sica GS. ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment. Journal of Crohn's and Colitis. 2024;18(10):1556-82.
P0781: Perianal lesions present at paediatric Crohn’s disease diagnosis require early treatment with tumour necrosis factor antagonist to reduce high risk of perianal fistulising complications: a post-hoc analysis of a prospective, multicentre studyECCO'25Year: 2025
Authors: Adler, J.(1)*;Gadepalli, S.(2);
(1)University of Michigan, Susan B. Meister Child Health Evaluation and Research Center, Ann Arbor, United States;(2)University of Michigan, Pediatric Surgery, Ann Arbor, United States; BISCUIT study group
1. Adler J, Dong S, Eder SJ, Dombkowski KJ, ImproveCareNow Pediatric IBDLHS. Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative. Journal of pediatric gastroenterology and nutrition. 2017;64:e117-e124
2. Adler J, Lin CC, Gadepalli SK, Dombkowski KJ. Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn Disease. JAMA Netw Open. 2020;3:e207378
3. Singer AAM, Bloom DA, Adler J. Factors Associated With Development of Perianal Fistulas in Pediatric Patients With Crohn's Disease. Clinical gastroenterology and hepatology. 2021;19:1071-1073.
P0782: Resetting the Clock: Does Redo IPAA Restore Quality of Life? Patient Reported Outcomes Before and After Redo Ileoanal Pouch SurgeryECCO'25Year: 2025
Authors: HolubarMD- MS, S.(1)*;Lavryk, O.(1);Lipman, J.(1);Kanters, A.(1);Cohen, B.(2);Falloon, K.(2);Rieder, F.(2);Qazi, T.(2);Gorgun, E.(1);Steele, S.(1);Liska, D.(1);
(1)Cleveland Clinic, Colon & Rectal Surgery, Cleveland, United States;(2)Cleveland Clinic, Gastroenterology & Hepatology, Cleveland, United States;
P0783: High risk of adrenal insufficiency in patients with Inflammatory Bowel Disease treated with a conventional course of systemic corticosteroids: Results from a prospective study.ECCO'25Year: 2025
Authors: Navarro Llavat, M.(1)*;García-Bosch, O.(1);Castro-Poceiro, J.(1);Bargalló García , A.(1);Blasco Pelicano, A.(1);Albareda Riera, M.(2);Domènech Morral , E.(3);
(1)Complex hospitalari universitari Moisès Broggi, Gastroenterology, Sant Joan Despí, Spain;(2)Complex hospitalari universitari Moisès Broggi, Endocrinology and Nutrition, Sant Joan Despí, Spain;(3)Hospital Germans Trias i Pujol. Centro de Investigaciones en Red en Enfermedades Hepáticas y Digestivas CIBEREHD., Gastroenterology, Badalona, Spain;
